Resistance Training Effects on Gut Microbiome and Cardiometabolic Outcomes
NCT ID: NCT04906525
Last Updated: 2023-03-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
34 participants
INTERVENTIONAL
2021-05-19
2022-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
How a Single Workout Affects Gut Bugs in Women With Different Fitness Levels and Body Types
NCT06691100
Anaerobic Exercise and Mental Acuity
NCT05850221
Exploring the Relationship Between the Gut Microbiome, Physical Fitness Levels and Metabolic Responses to Exercise
NCT05220657
Distinct Exercise Modalities on Gut Microbiome
NCT06545123
The Effects of a 12-week Combined Exercise Intervention on the Gut Microbiome of Older Adults
NCT06153719
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Conventional physical activity guidelines
Participants are given recommendations on physical activity guidelines
Conventional physical activity guidelines
Participants are given recommendations on physical activity guidelines
Resistance training
Participants will undergo 6 weeks of supervised resistance training
Resistance training
Participants will undergo 6 weeks of supervised resistance training
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Resistance training
Participants will undergo 6 weeks of supervised resistance training
Conventional physical activity guidelines
Participants are given recommendations on physical activity guidelines
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI: 25-45 kg/m2
* Sedentary lifestyle
* Consistent diet patterns
* Weight-stable (\<4 kg change over the last 3 mo)
* Willingness to adhere to resistance training protocol and not change diet
* Non-smoker \>1 year or more
Exclusion Criteria
* Recent start of medications that affect metabolism or appetite
* Antibiotics
* Diabetes
* Drug therapy for coronary artery disease, peripheral artery disease, congestive heart failure, or dyslipidemia
* Uncontrolled hypertension and blood pressure ≥ 180/110
* Gastrointestinal disease and/or bariatric surgery
* Smoking
* Illicit drug use
* Pregnant or lactating individuals
18 Years
35 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Missouri-Columbia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jaapna Dhillon
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jaapna Dhillon, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Missouri-Columbia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Missouri
Columbia, Missouri, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2054484
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.